BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AviaraDx, Inc. Announces Presentation At The Pacific Growth Equities 2006 Life Sciences Growth Conference June 14, 2006


5/25/2006 11:12:26 AM

CARLSBAD, Calif., May 25 /PRNewswire/ -- AviaraDx, Inc., a leader in molecular cancer profiling to enable personalized medicine, announced today that Antonius Schuh, Ph.D., the Company's Chief Executive Officer, will present at the Pacific Growth Equities 2006 Life Sciences Growth Conference on Wednesday, June 14, at 10:30 a.m. PDT in the Stanford Room of the InterContinental Mark Hopkins Hotel in San Francisco.

Dr. Schuh will provide an update on the exciting developments related to the company's molecular cancer profiling technologies and business opportunities for tumor identification, patient prognosis and prediction of response to cancer therapies. In addition, he will address the company's development and commercial plans in the context of its commercial cancer diagnostic partnerships with Quest, LabCorp and Agendia.

About AviaraDx, Inc.

AviaraDx, Inc., is focused on developing and commercializing molecular diagnostic technologies to enable personalized medicine in cancer treatment. As a leader in molecular cancer profiling technologies, AviaraDx is targeting the oncology market with three first-in-class diagnostic technologies: Molecular Cancer Identification (MCID), Breast Cancer Profiling (BCP) and Drug Response Profiling (DRP). To date, AviaraDx has licensed its MCID and BCP technologies for specific clinical indications to Quest Diagnostics, Laboratory Corporation of America and Agendia BV in order to drive early market penetration and acceptance. AviaraDx, formerly Arcturus Bioscience, has recently relocated its headquarters from Mountain View, California, to Carlsbad, California. Please visit the AviaraDx website at http://www.aviaradx.com for more information.

About Pacific Growth Equities Life Sciences Growth Conference

Pacific Growth Equities, an investment bank specializing in emerging growth companies, is hosting its annual Life Sciences Growth Conference on June 12-14, 2006 at the InterContinental Mark Hopkins Hotel in San Francisco. Institutional investors, venture capitalists and life sciences industry insiders will focus on and interact with senior management from over 170 leading public and private companies with the highest growth potential in the second half of 2006 and beyond.

CONTACT: Steve Zaniboni Chief Financial Officer +1-760-579-0514

AviaraDx, Inc.

CONTACT: Steve Zaniboni, Chief Financial Officer, of AviaraDx, Inc.,+1-760-579-0514



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES